States / U.S. Congress / HR 3029
HR 3029 Passed First Chamber
To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Jul 21, 2026 · Senate
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
Jul 20, 2026 · House
Motion to reconsider laid on the table Agreed to without objection.
Jul 20, 2026 · House
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4666)
Jul 20, 2026 · House
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4666)
Jul 20, 2026 · House
DEBATE - The House proceeded with forty minutes of debate on H.R. 3029.
Jul 20, 2026 · House
Considered under suspension of the rules. (consideration: CR H4666-4667)
Jul 20, 2026 · House
Mr. Babin moved to suspend the rules and pass the bill, as amended.
Jul 16, 2026 · House
Placed on the Union Calendar, Calendar No. 654.
Jul 16, 2026 · House
Reported by the Committee on Science, Space, and Technology. H. Rept. 119-751.
Apr 29, 2025 · House
Ordered to be Reported by Voice Vote.
Apr 29, 2025 · House
Committee Consideration and Mark-up Session Held
Apr 28, 2025 · House
Referred to the House Committee on Science, Space, and Technology.
Apr 28, 2025 · House
Introduced in House